Does abnormal neuronal excitability exist in myotonic dystrophy? II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia

Neurological Sciences

Volumn 21, Issue 2, 2000, Pages 81-86

  Di Costanzo, A ^a   Mottola, A ^a   Toriello, A ^a   Di Iorio, G ^a   Tedeschi, G ^a   Bonavita, V ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Apathy; Hypersomnia; Myotonic dystrophy; Quinidine

Indexed keywords

ANTIARRHYTHMIC AGENT; DIHYDROQUINIDINE; QUINIDINE DERIVATIVE;

ADULT; APATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; EPIGASTRIC PAIN; FEMALE; HUMAN; HYPERSOMNIA; MALE; MYOTONIC DYSTROPHY; NAUSEA; NERVE CELL EXCITABILITY; RANDOMIZED CONTROLLED TRIAL; SLEEP TIME;

ANTI-ARRHYTHMIA AGENTS; CROSS-OVER STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; DOUBLE-BLIND METHOD; HUMANS; MEDICAL RECORDS; MOOD DISORDERS; MYOTONIC DYSTROPHY; NEURONS; QUINIDINE; SLEEP;

EID: 0033922915     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720070100     Document Type: Article

References (40)

1. Harper PS, Rüdel R (1994) Myotonic dystrophy. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1192-1219
2. Korade-Mirnics Ž, Babitzke P, Hoffman E (1998) Myotonic dystrophy: molecular windows on a complex etiology. Nucleic Acids Res 26:1363-1368
3. Di Costanzo A, Mottola A, Toriello A, Di Iorio G, Tedeschi G, Bonavita V (2000) Does abnormal neuronal excitability exist in myotonic dystrophy? I. Effects of the antiarrhythmic drug hydroquinidine on slow saccadic eye movements. Neurol Sci 21:73-80
4. Chimienti M, Regazzi MB, La Rovere MT. Salerno JA, Previtali M, Montericcio V. Rondanelli R, Montemartini C (1988) Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration. Cardiovasc Drugs Ther 2:679-686
5. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of apathy evaluation scale. Psychiatry Res 38:143-162
6. Andersson S, Krogstad JM, Finset A (1999) Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med 29:447-456
7. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
8. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, revised third edition. American Psychiatric Association, Washington DC
9. Marin RS (1997) Apathy and related disorders of diminished motivation. In: Dickstein LJ, Riba MD, Oldham JM (eds) Review of psychiatry. American Psychiatric, Washington, pp 205-242
10. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I (1998) Apathy is not depression. J Neuropsychiatry Clin Neurosci 10:314-319
11. Bungener C, Jouvent R, Delaporte C (1998) Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry 65:353-356
12. Delaporte C (1998) Personality patterns in patients with myotonic dystrophy. Arch Neurol 55:635-640
13. Rubinsztein JS, Rubinsztein DC, Goodburn S, Holland AJ (1998) Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 64:510-515
14. Brumback RA (1987) Disturbed personality and psychosocial adjustment in myotonic dystrophy: relationship to intellectual/cognitive function and underlying affective disorder (depression). Psychol Rep 60:783-796
15. Robbins TW, Everitt BJ (1999) Motivation and reward. In: Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR (eds) Fundamental neuroscience. Academic. San Diego London, pp 1245-1260
16. Begin P, Mathieu J, Almirall J, Grassino A (1997) Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 156:133-139
17. Cirignotta F, Mondini S, Zucconi M, Barrot-Cortes E, Sturani C, Schiavina M, Coccagna G, Lugaresi E (1987) Sleep-related breathing impairment in myotonic dystrophy. J Neurol 235:80-85
18. Guilleminault C, Cummiskey J, Motta J, Lynne-Davies P (1978) Respiration and haemodynamic study during wakefulness and sleep in myotonic dystrophy. Sleep 1:19-31
19. van Hilten JJ, Kerkhof GA, van Dijk JG, Dunnewold R, Wintzen AR (1993) Disruption of sleep-wake rhythmicity and daytime sleepiness in myotonic dystrophy. J Neurol Sci 114:68-75
20. Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H, Mitake S, Inagaki T, Yamano T, Shimizu N, Nagao K (1998) Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology 51:1121-1124
21. Ono S, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Kurisaki H. Mitake S, Inagaki T, Yamano T, Shimizu N, Nagao K (1998) Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology 50:535-538
22. van der Meché FGA, Bogaard JM, van der Sluys JCM Schimsheimer RJ, Ververs CCM, Busch HFM (1994) Daytime sleep in myotonic dystrophy is not caused by sleep apnoca. J Neurol Neurosurg Psychiatry 57:626-628
23. Yoshida S, Fujimura K, Matsuda Y (1986) Effects of quinidine and quinine on the excitability of pyramidal neurons in guinea-pig hippocampal slices. Pflügers Arch 406:544-546
24. Hermann A, Gorman ALF (1984) Action of quinidine on ionic currents of molluscan pacemaker neurons. J Gen Physiol 83:919-940
25. Pelassy C, Aussel C (1993) Effect of Cinchona bark alkaloids and chloroquine on phospholipid synthesis. Pharmacology 47:28-35
26. Surewicz WK, Jozwiak Z (1983) Effect of quinidine on membrane properties. Depression of the lipid phase transition temperature and changes in the permeability of the lipid bilayer. Biochem Pharmacol 32:1467-1471
27. Clement EM, Grahame-Smith DG, Elliott JM (1998) Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue. Neuropharmacology 37:945-951
28. Cohen-Armon M, Henis YI, Kloog Y, Sokolovsky M (1985) Interactions of quinidine and lidocaine with rat brain and heart muscarinic receptors. Biochem Biophys Res Commun 127:326-332
29. Ogata N, Yoshii M, Narahashi T (1989) Psychotropic drugs block voltage-gated ion channels in neuroblastoma cells. Brain Res 476:140-144
30. Phillips MF, Steer HM, Soldan JR, Wiles CM, Harper PS (1999) Daytime somnolence in myotonic dystrophy. J Neurol 246:275-282
31. Broughton R, Stuss D, Kates M, Roberts J, Dunham W (1990) Neuropsychological deficits and sleep in myotonic dystrophy. Can J Neurol Sci 17:410-415
32. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S (1986) Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9:519-524
33. Doghramji K, Mitler MM, Sangal RB, Shapiro C, Taylor S, Walsleben J, Belisle C, Erman MK, Hayduk R, Hosn R, O'Malley EB, Sangal JM, Schutte SL, Youakim JM (1997) A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol 103:554-562
34. Roden DM (1996) Antiarrhythmic drugs. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds) Goodman & Gilman's The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 839-874
35. Grace AA, Camm AJ (1998) Quinidine. N Engl J Med 338:35-45
36. Griggs RC, Davis RJ, Anderson DC, Dove JT (1975) Cardiac conduction in myotonic dystrophy. Am J Med 59:37-42
37. Mielke U, Haass A, Sen S, Schmidt W (1985) Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert. J Neurol 232:271-274
38. Kwiecinski H, Ryniewicz B, Ostrzycki A (1992) Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 86:371-375
39. Phillips MF, Harper PS (1997) Cardiac disease in myotonic dystrophy. Cardiovasc Res 33:13-22
40. Colleran JA, Hawley RJ, Pinnow EE, Kokkinos PF, Fletcher RD (1997) Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am J Cardiol 80:1494-1497